RYSE Asset Management
RYSE Golden Opportunities Fund is a closed-end alternative investment fund regulated by CMVM (ID: 2434) and managed by RYSE Asset Management, investing in venture capital with a minimum commitment of €100,000 and a 8 years lock-up period. It charges a 0.5% management fee and a 20% performance fee, is open for subscriptions and has not confirmed its US-person status.
| Min Investment | €100,000 |
|---|---|
| Open to US | Not confirmed |
| Lock-up | 8 years |
| Fund Size (AUM) | Not disclosed |
| Management Fee | 0.5% |
|---|---|
| Performance Fee | 20% |
| CMVM ID | 2434 |
|---|---|
| Regulated By | CMVM |
Figures are reported by the fund manager.
Capital at risk. Past performance isn't indicative of future returns. Figures are shown in euro (EUR); fees reduce returns, and for investors funding from another currency amounts may rise or fall with exchange rates. This is not investment advice.
How these fees compare across all tracked funds: Golden Visa Fund Fee Index
About €15,000 in reported fund fees over 6 years on €500,000
Fees this fund has not reported are not included.
Not in the total because the fund has not reported them: subscription fee, redemption fee.
Fees are fund-reported and simplified: actual fee bases, hurdles and timing vary by fund. This is an illustration, not a quote or a forecast. It leaves out legal, application, tax, FX and bank costs. Capital is at risk.
We'll email you the fees and terms listed for RYSE Golden Opportunities Fund, the 6-year cost table for your amount, plus the questions to ask the manager before you invest.
Investor decision panel
Golden Visa note: The manager states this fund is intended for Golden Visa applicants, but this claim is not shown as independently verified here.
The RYSE Golden Opportunities Fund invests exclusively in high growth digital health companies that are transforming how healthcare is delivered and financed. The strategy focuses on proven, revenue generating businesses that deliver measurable economic value to healthcare systems scalable, asset‑light models with strong competitive moats and clear paths to profitability. As the only Golden Visa fund dedicated to digital healthcare, it offers investors focused exposure to a sector undergoing structural, long‑term expansion, underpinned by rigorous research, disciplined risk management, and deep sector expertise.
We source from CMVM-regulated managers where applicable. Verify each fund's registration and GV suitability with counsel.
| CMVM Registration | 2434 |
|---|---|
| ISIN | PTFXOPIM0009 |
| Minimum Investment | €100,000 |
|---|---|
| Fund Structure | Venture Capital |
| Lock-up Period | 8 years |
| Domicile | Portugal |
| Custodian | Not disclosed |
| Auditor | Not disclosed |
| ISIN | PTFXOPIM0009 |
| Typical Ticket | Not disclosed |
| Risk Band | Not disclosed |
| Fund Status | Open |
| Inception Date | Not disclosed |
Figures are reported by the fund manager. Terms may vary by investor class.
We'll email you if the status or fees listed for RYSE Golden Opportunities Fund change, including if it closes to new investors.
View all funds in this category
Always confirm regulatory details with the fund manager and legal counsel before investing.
Team information coming soon
Have questions about RYSE Golden Opportunities Fund? Our specialists can help with eligibility, fees, timelines, and how it fits your Golden Visa plan — free and with no obligation.
Disclaimer: Your enquiry goes to Movingto. Movingto does not provide investment advice or introduce visitors directly to fund managers from this site. Capital is at risk. Target returns are fund-stated objectives, not forecasts or guarantees. Confirm all details against the fund prospectus/KID and qualified advisers.
You invest in units or shares of the fund, not directly in its underlying assets. Investment in funds involves risks, including the possible loss of principal. Where a fund is described as sustainable, ESG, or impact-oriented, those characteristics reflect the fund's own disclosures — check the fund's documents and any SFDR classification; a sustainability label does not by itself determine return or risk. Please read all fund documentation carefully before making any investment decisions. Past performance is not indicative of future results.
No published fund-stated objective
This fund hasn't specified a fund-stated objective, so no return is assumed. Enter your own assumption below to model an outcome — any figure you enter is your own, not the fund's.Ask Movingto what disclosure is missing, then confirm any objective against current fund documents.
Project potential returns based on your investment parameters
Display returns after disclosed management and performance fees
Fund minimum: €100,000
Typical holding period
No published fund target — enter your own assumption
No published fund-stated objective: This fund hasn't specified a return objective, so no return is assumed. Any figure here is your own assumption, not the fund's or a Movingto projection. Actual performance may differ significantly, and capital is at risk. Confirm fund-specific information against current fund documents and qualified advisers.
Investment Risk Disclosure: The figures shown are an illustration, not a forecast. They are an estimate of future performance based on your own assumptions and on how this type of investment has behaved and/or on current market conditions, and are not an exact indicator — what you actually get will vary with market performance and how long you stay invested. This investment may result in a financial loss, as there is no capital guarantee. Past performance does not guarantee future results. Any future return is also subject to taxation, which depends on your personal situation and may change. Figures are shown in euro (EUR); if you fund from another currency, the amounts you pay and receive may rise or fall with exchange-rate movements. Confirm details against the fund's own documents and a qualified financial adviser before making any investment decision.
The IMGA Futurum Tech Fund is a specialised Venture Capital Fund (FCR) regulated by the CMVM and domiciled in Portugal. The fund targets high-growth technology companies in the "Atlantic Corridor" through a strategic partnership between IM Gestão de Ativos (IMGA), Portugal's largest independent asset manager, and Futurum Capital. It is marketed for the Golden Visa route via the Capital Transfer option, with eligibility subject to legal confirmation with zero real estate exposure, focusing on scalable startups bridging the Brazilian and Portuguese ecosystems.
IM Gestão de Ativos (IMGA)A CMVM-regulated Portuguese closed-end venture capital fund (FCR) managed by Indico Capital Partners and registered with CMVM under number 2356. Movingto has not yet independently verified the fund's Golden Visa eligibility basis or detailed terms.
LXL Ventures employs a hybrid portfolio strategy, 40% in U.S. companies, 35% in established Portuguese market names, and 25% in early-stage Portuguese technology companies. The tech sleeve is the key differentiator, embedding investors into Portugal's innovation ecosystem in a way that unlocks the country's new tax benefit scheme. The overall structure is designed to feel familiar to American investors while delivering European residency, EU mobility, and a pathway to Portuguese citizenship, all within a framework built for dual U.S. and Portuguese compliance.
The Atlantic Bond Fund is an Open-ended Alternative Investment Fund designed and managed by 3 Comma Capital. The fund aims to provide its participants with capital appreciation over a five-year period, with an investment policy designed to achieve absolute returns within the recommended investment horizon (100% bond fund).
3 Comma CapitalThe 3CC Portugal Golden Income Fund is an open-ended, CMVM-regulated alternative investment fund managed by 3 Comma Capital. It blends stable income from Portuguese corporate bonds with growth exposure to U.S. and global equities, digital assets and gold, while meeting all eligibility requirements for the Portuguese Golden Visa.
3 Comma CapitalThe Alpha Fund is a private equity fund focused on special situations. Its primary objective is to invest in companies with sound business models but distressed balance sheets, typically resulting from external events that have impacted their financial structure in recent years. The fund is currently open for subscription and is eligible for the Golden Visa programme, offering investors both attractive return potential and residency benefits.
ActiveCap - Capital PartnersIf this fund is full or doesn't meet your requirements, here are similar options with comparable risk profiles and investment strategies.
A CMVM-regulated, VC fund with access to European high-growth startups and corporates. Offers an option to qualify for IFICI tax regime (NHR 2.0).
The IMGA Futurum Tech Fund is a specialised Venture Capital Fund (FCR) regulated by the CMVM and domiciled in Portugal. The fund targets high-growth technology companies in the "Atlantic Corridor" through a strategic partnership between IM Gestão de Ativos (IMGA), Portugal's largest independent asset manager, and Futurum Capital. It is marketed for the Golden Visa route via the Capital Transfer option, with eligibility subject to legal confirmation with zero real estate exposure, focusing on scalable startups bridging the Brazilian and Portuguese ecosystems.
LXL Ventures employs a hybrid portfolio strategy, 40% in U.S. companies, 35% in established Portuguese market names, and 25% in early-stage Portuguese technology companies. The tech sleeve is the key differentiator, embedding investors into Portugal's innovation ecosystem in a way that unlocks the country's new tax benefit scheme. The overall structure is designed to feel familiar to American investors while delivering European residency, EU mobility, and a pathway to Portuguese citizenship, all within a framework built for dual U.S. and Portuguese compliance.
Compare RYSE Golden Opportunities Fund with similar investment funds to analyze performance, fees, and investment requirements.
Verify current subscription documents, fee schedule, liquidity terms, tax treatment, custodian/auditor evidence, and fund-route evidence with Portuguese legal counsel. Current key unknowns: Fund size, Custodian, Auditor, Redemptions.
This profile currently has limited data completeness (64%). No major flags are currently detected.
No. Verification means selected regulatory, identity, and document checks have been reviewed. It is not financial advice, a suitability assessment, or a guarantee of a Golden Visa outcome or investment performance.
The listed minimum investment is €100,000. Redemption frequency is not disclosed and lock-up is 8 years. Confirm final terms in the fund documents.
Management fee: 0.5%. Performance fee: 20%. Subscription fee: Not disclosed. Missing fee fields should be treated as diligence gaps, not as zero-cost assumptions.
No fund-specific return objective is disclosed. Stated objectives are set by the fund and are not forecasts or guarantees. Past performance does not indicate future results and capital is at risk.
The profile lists CMVM ID 2434. Registration is a securities-regulation status, not a quality or Golden Visa signal — verify current registry status and documents before subscribing.
The profile marks this fund as Golden Visa intended by its manager. Fund-route evidence must still be confirmed against current law, fund documents, and the applicant's own legal file — eligibility is assessed per application, not guaranteed by the fund.
How does this Venture Capital fund stack up?
Compare fees, returns, and key terms across all Venture Capital Golden Visa funds.
See how this fund compares to other Venture Capital Golden Visa funds →Looking for all Golden Visa funds in one place?
Browse every fund with fees, returns, and key details side by side.
View the Complete Fund Directory →